Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Klothos Neurosciences Inc. (KLTO:NASDAQ), powered by AI.
Klothos Neurosciences Inc. is currently trading at $0.52. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Klothos Neurosciences Inc. on Alpha Lenz.
Klothos Neurosciences Inc.'s P/E ratio is -1.6.
“Klothos Neurosciences Inc. trades at a P/E of -1.6 (undervalued) with modest ROE of -518.9%.”
Ask for details →Klothos Neurosciences Inc. is a cutting-edge biotechnology company devoted to the development of innovative therapies for neurological disorders. This organization leverages advanced scientific research and cutting-edge technology to address complex diseases impacting the brain and nervous system, such as Alzheimer's, Parkinson's, and other neurodegenerative conditions. By focusing on breakthrough innovations and targeted treatment approaches, Klothos Neurosciences aims to improve patient outcomes and quality of life significantly. Anchored in a robust pipeline of drug candidates and a commitment to scientific excellence, Klothos collaborates with key stakeholders, including research institutions and healthcare providers, to drive progress in neuroscience. As a participant in the biotechnology sector, the company contributes significantly to the broader healthcare and life sciences industries, offering potential solutions to unmet medical needs. With its headquarters poised at the intersection of technology and medicine, Klothos Neurosciences remains a pivotal player in the relentless pursuit to conquer neurological illnesses through scientifically backed therapies.
“Klothos Neurosciences Inc. trades at a P/E of -1.6 (undervalued) with modest ROE of -518.9%.”
Ask for details →Klothos Neurosciences Inc. (ticker: KLTO) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 3 employees. Market cap is $10M.
The current price is $0.524 with a P/E ratio of -1.64x and P/B of 8.51x.
ROE is -518.87%.